deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03378323

Single Versus Multiple Injections for Axillary Plexus Block

Single Versus Multiple Injections for Axillary Plexus Block: a Randomized Controlled Trial

Sponsor: Hôpital du Valais

Updated 7 times since 2018 Last updated: Apr 10, 2019 Started: Jul 1, 2018 Primary completion: Apr 9, 2019 Completion: Apr 10, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03378323, this PHASE4 trial focuses on Upper Extremity and remains completed. Sponsored by Hôpital du Valais, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotNot Yet Recruiting~Nov 2018 – ~May 2019 · 6 months · monthly snapshotRecruiting~May 2019 – ~Jan 2021 · 20 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. May 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  5. Nov 2018 — May 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

Show 2 earlier versions
  1. Jun 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE4

  2. Jan 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hôpital du Valais
  • University of Lausanne Hospitals
Data source: Hôpital du Valais

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations